Fennec Pharmaceuticals (FENC) Accounts Payables: 2011-2025
Historic Accounts Payables for Fennec Pharmaceuticals (FENC) over the last 15 years, with Sep 2025 value amounting to $5.9 million.
- Fennec Pharmaceuticals' Accounts Payables rose 51.69% to $5.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.9 million, marking a year-over-year increase of 51.69%. This contributed to the annual value of $3.2 million for FY2024, which is 14.21% down from last year.
- As of Q3 2025, Fennec Pharmaceuticals' Accounts Payables stood at $5.9 million, which was down 1.26% from $5.9 million recorded in Q2 2025.
- Fennec Pharmaceuticals' Accounts Payables' 5-year high stood at $5.9 million during Q2 2025, with a 5-year trough of $677,000 in Q2 2021.
- Its 3-year average for Accounts Payables is $4.2 million, with a median of $3.9 million in 2024.
- Its Accounts Payables has fluctuated over the past 5 years, first crashed by 75.43% in 2021, then skyrocketed by 157.46% in 2022.
- Quarterly analysis of 5 years shows Fennec Pharmaceuticals' Accounts Payables stood at $1.2 million in 2021, then soared by 119.50% to $2.4 million in 2022, then skyrocketed by 58.08% to $3.8 million in 2023, then decreased by 14.21% to $3.2 million in 2024, then soared by 51.69% to $5.9 million in 2025.
- Its Accounts Payables stands at $5.9 million for Q3 2025, versus $5.9 million for Q2 2025 and $5.3 million for Q1 2025.